898 related articles for article (PubMed ID: 10518394)
1. [Comparison of the efficacy of traditional antidepressive agents and the new generation of antidepressives in the treatment of depressive disorders].
Cvjetković-Bosnjak M; Knezević A; Soldatović-Stajić B
Med Pregl; 1999; 52(3-5):108-11. PubMed ID: 10518394
[TBL] [Abstract][Full Text] [Related]
2. Fluoxetine versus other types of pharmacotherapy for depression.
Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997
[TBL] [Abstract][Full Text] [Related]
3. An analysis of the diffusion of new antidepressants: variety, quality, and marketing efforts.
Berndt ER; Bhattacharjya A; Mishol DN; Arcelus A; Lasky T
J Ment Health Policy Econ; 2002 Mar; 5(1):3-19. PubMed ID: 12529566
[TBL] [Abstract][Full Text] [Related]
4. Amitriptyline for depression.
Guaiana G; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2007 Jul; (3):CD004186. PubMed ID: 17636748
[TBL] [Abstract][Full Text] [Related]
5. Amitriptyline versus other types of pharmacotherapy for depression.
Guaiana G; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2003; (2):CD004186. PubMed ID: 12804503
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis.
MacGillivray S; Arroll B; Hatcher S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I
BMJ; 2003 May; 326(7397):1014. PubMed ID: 12742924
[TBL] [Abstract][Full Text] [Related]
7. Combined treatment with venlafaxine and tricyclic antidepressants in depressed patients who had partial response to clomipramine or imipramine: initial findings.
Gómez Gómez JM; Teixidó Perramón C
J Clin Psychiatry; 2000 Apr; 61(4):285-9. PubMed ID: 10830150
[TBL] [Abstract][Full Text] [Related]
8. [Paroxetine versus clomipramine in female adolescents suffering from anorexia nervosa and depressive episode--a retrospective study on tolerability, reasons for discontinuing the antidepressive treatment and different outcome measurements].
Strobel M; Warnke A; Roth M; Schulze U
Z Kinder Jugendpsychiatr Psychother; 2004 Nov; 32(4):279-89. PubMed ID: 15565897
[TBL] [Abstract][Full Text] [Related]
9. Antidepressants in the treatment of migraine headache.
Punay NC; Couch JR
Curr Pain Headache Rep; 2003 Feb; 7(1):51-4. PubMed ID: 12525271
[TBL] [Abstract][Full Text] [Related]
10. Fluvoxamine and clomipramine in depressed hospitalised patients: results from a randomised, double-blind study.
Ottevanger EA
Encephale; 1995; 21(4):317-21. PubMed ID: 7588171
[TBL] [Abstract][Full Text] [Related]
11. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
Anderson IM
Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.
Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
Cochrane Database Syst Rev; 2000; (4):CD002791. PubMed ID: 11034764
[TBL] [Abstract][Full Text] [Related]
13. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
[TBL] [Abstract][Full Text] [Related]
14. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.
Wheatley DP; van Moffaert M; Timmerman L; Kremer CM
J Clin Psychiatry; 1998 Jun; 59(6):306-12. PubMed ID: 9671343
[TBL] [Abstract][Full Text] [Related]
15. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder.
López-Ibor JJ; Saiz J; Cottraux J; Note I; Viñas R; Bourgeois M; Hernández M; Gómez-Pérez JC
Eur Neuropsychopharmacol; 1996 May; 6(2):111-8. PubMed ID: 8791036
[TBL] [Abstract][Full Text] [Related]
16. Comparison of tolerance of venlafaxine, paroxetine and amitriptyline in depression therapy.
Miskovic M
Med Arch; 2015 Apr; 69(2):107-9. PubMed ID: 26005260
[TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
[TBL] [Abstract][Full Text] [Related]
18. Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials.
Barbui C; Hotopf M
Br J Psychiatry; 2001 Feb; 178():129-44. PubMed ID: 11157426
[TBL] [Abstract][Full Text] [Related]
19. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
Anderson IM
J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
[TBL] [Abstract][Full Text] [Related]
20. [Mirtazapine versus other antidepressive agents for depression].
Knud Larsen J
Ugeskr Laeger; 2012 Nov; 174(46):2864-6. PubMed ID: 23153468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
